{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:39:04Z","timestamp":1790224744504,"version":"4.1.0"},"reference-count":59,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1997,5]]},"abstract":"<jats:p>In a comparative study on the effects of predictive DNA testing for late onset disorders, pre-test psychological distress was assessed in people at risk for Huntington's disease (HD, n = 41), cerebral haemorrhage (HCHWA-D, n = 9), breast and ovarian cancer (HBOC, n = 24), and polyposis coli (FAP, n = 45). Partners, if available, also participated in the study. Distress was measured with the subscales Intrusion and Avoidance of the Impact of Event Scale. People at risk for the neurodegenerative disorders reported more avoidance than those at risk for the cancer syndromes. People at risk for FAP and partners of those at risk for HBOC reported less intrusion than the others at risk and the other partners. Subjects who were more distressed reported more experiences with the disease in close relatives, the disease having a great impact on their lives, having considerations against predictive testing, expecting that being identified as a gene carrier would have adverse effects, and expecting relief after being identified as a non-carrier. Test candidates who expected an increase of personal problems showed higher avoidance, whereas those who could better anticipate future life as a carrier had higher intrusion levels. Generally, subjects with high distress levels are of more concern to the healthcare professional than those with low distress levels. However, high distress may reflect worrying as a mental preparation for the test result, whereas low distress may indicate denial-avoidance behaviour and poor anticipation of the test outcome. In pre-test counselling sessions, this should be acknowledged and addressed.<\/jats:p>","DOI":"10.1136\/jmg.34.5.382","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:37:21Z","timestamp":1226331441000},"page":"382-390","source":"Crossref","is-referenced-by-count":59,"title":["Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam\/Leiden Genetics Workgroup."],"prefix":"10.1136","volume":"34","author":[{"given":"A C","family":"DudokdeWit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tibben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Duivenvoorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Frets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M W","family":"Zoeteweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Losekoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"van Haeringen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Niermeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Passchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1997,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook, J.D.; McCurrach, M.E.; Harley, H.G.","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.410360303","article-title":"Familial Alzheimer's disease","volume":"36","author":"Bird, T.D.","year":"1994","unstructured":"Bird TD. Familial Alzheimer's disease. Ann Neurol 1994;36: 335-6.","journal-title":"Ann Neurol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ana.410360307","article-title":"Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description","volume":"36","author":"Haltia, M.; Viitanen, M.; Sulkava, R.","year":"1994","unstructured":"Haltia M, Viitanen M, Sulkava R, et al. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 1994;36:362-7.","journal-title":"Ann Neurol"},{"key":"ref_5","first-page":"518","article-title":"DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type)","volume":"49","author":"Bakker, E.; van Broeckhoven, C.; Haan, J.","year":"1991","unstructured":"Bakker E, van Broeckhoven C, Haan J, et al. DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 1991;49:518-21.","journal-title":"Am J Hum Genet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster, R.; Neuhausen, S.L.; Mangion, J.","year":"1994","unstructured":"Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki, Y.; Swensen, J.; Shattuck-Eidens, D.","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1651562","article-title":"Identification of FAP locus genes from chromosome 5q21","volume":"253","author":"Kinzler, K.W.; Nilbert, M.C.; Su, L.K.","year":"1991","unstructured":"Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253: 661-5.","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0092-8674(81)90021-0","article-title":"Identification and characterization of the familial adenomatous polyposis coli gene","volume":"66","author":"Groden, J.; Thliveris, A.; Samowitz, W.","year":"1991","unstructured":"Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.","journal-title":"Cell"},{"key":"ref_10","first-page":"1060","article-title":"Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis","volume":"56","author":"Wijnen, J.; Vasen, H.; Khan, P.M.","year":"1995","unstructured":"Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995;56: 1060-6.","journal-title":"Am J Hum Genet"},{"key":"ref_11","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511570049.017","article-title":"Predictive genetics: the cultural implications of supplying probable futures","volume-title":"The troubled helix; social and psychological implications of the new human genetics","author":"Davison, C.","year":"1996","unstructured":"Davison C. Predictive genetics: the cultural implications of supplying probable futures. In: Marteau TM, Richards MPM, eds. The troubled helix; social and psychological implications of the new human genetics. Cambridge: Cambridge University Press, 1996."},{"key":"ref_12","first-page":"189","article-title":"Ethical issues in genetic testing for Huntington's disease: lessons for the study of familial cancers","volume":"10","author":"Harper, P.","year":"1992","unstructured":"Harper P. Ethical issues in genetic testing for Huntington's disease: lessons for the study of familial cancers. Dis Markers 1992;10:189-93.","journal-title":"Dis Markers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1099-1611(199609)5:3<223::AID-PON237>3.0.CO;2-X","article-title":"BRCA1 testing: some issues in moving from research to service","volume":"5","author":"Ponder, M.; Green, J.M.","year":"1996","unstructured":"Ponder M, Green JM. BRCA1 testing: some issues in moving from research to service. Psycho-Oncology 1996;5:223-32.","journal-title":"Psycho-Oncology"},{"key":"ref_14","first-page":"603","article-title":"Uptake of presymptomatic predictive testing for Huntington's disease","volume":"ii:","author":"Craufurd, D.; Dodge, A.; Kerzin-Storrar, L.; Harris, R.","year":"1989","unstructured":"Craufurd D, Dodge A, Kerzin-Storrar L, Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989;ii:603-5.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/0140-6736(92)92610-R","article-title":"Understanding the low uptake of presymptomatic DNA testing for Huntington's disease","volume":"340","author":"Tibben, A.; Niermeijer, M.F.; Roos, R.A.C.","year":"1992","unstructured":"Tibben A, Niermeijer MF, Roos RAC, et al. Understanding the low uptake of presymptomatic DNA testing for Huntington's disease. Lancet 1992;340:1416.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajmg.1320450112","article-title":"Reluctance to undergo predictive testing: the case of Huntington disease","volume":"45","author":"Quaid, K.A.; Morris, M.","year":"1993","unstructured":"Quaid KA, Morris M. Reluctance to undergo predictive testing: the case of Huntington disease. Am J Med Genet 1993;45:41-5.","journal-title":"Am J Med Genet"},{"key":"ref_17","first-page":"1885","article-title":"BRCA1 testing in families with hereditary breast-ovarian cancer","volume":"275","author":"Lerman, C.; Narod, S.; Schulman, K.","year":"1996","unstructured":"Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. _JAMA 1996;275: 1885-92.","journal-title":"_JAMA"},{"key":"ref_18","article-title":"Erfelijkheidsvoorlichting en de ziekte van Huntington. (Genetic information and Huntington's disease)","volume-title":"DNA-diagnostiek voor erfelijke, later in het leven optredende, ziekten","author":"Maat-Kievit, J.A.","year":"1996","unstructured":"Maat-Kievit JA. Erfelijkheidsvoorlichting en de ziekte van Huntington. (Genetic information and Huntington's disease). In: Tibben A, Beemer FA, Brunner HG, eds. Presymptomatische DNA-diagnostiek voor erfelijke, later in het leven optredende, ziekten. Rotterdam: Bureau PAOG, Erasmus Universiteit Rotterdam, 1996."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archneur.1996.00550010053016","article-title":"White matter lesions and cognitive deterioration in presymptomatic carriers of the amyloid precursor gene codon 693 mutation","volume":"53","author":"Bornebroek, M.; Haan, J.; van Buchem, M.A.","year":"1996","unstructured":"Bornebroek M, Haan J, van Buchem MA, et al. White matter lesions and cognitive deterioration in presymptomatic carriers of the amyloid precursor gene codon 693 mutation. Arch Neurol 1996;53:43-8.","journal-title":"Arch Neurol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ajmg.1320420416","article-title":"Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk","volume":"42","author":"Bloch, M.; Adam, S.; Wiggins, S.; Huggins, M.; Hayden, M.R.","year":"1992","unstructured":"Bloch M, Adam S, Wiggins S, Huggins M, Hayden MR. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J. Med Genet 1992;42:499-507.","journal-title":"Am J. Med Genet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajmg.1320540303","article-title":"Self-selection in predictive testing for Huntington's disease","volume":"54","author":"Codori, A.M.; Hanson, R.; Brandt, J.","year":"1994","unstructured":"Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet 1994;54: 167-73.","journal-title":"Am J Med Genet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajmg.1320320215","article-title":"Predictive testing for Huntington disease. II. Demographic characteristics, lifestyle patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates","volume":"32","author":"Bloch, M.; Fahy, M.; Fox, S.; Hayden, M.R.","year":"1989","unstructured":"Bloch M, Fahy M, Fox S, Hayden MR. Predictive testing for Huntington disease. II.Demographic characteristics, lifestyle patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J7 Med Genet 1989;32: 217-24.","journal-title":"Am J7 Med Genet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bmj.298.6677.892-b","article-title":"Predictive testing for Huntington's disease","volume":"298","author":"Craufurd, D.; Harris, R.","year":"1989","unstructured":"Craufurd D, Harris R. Predictive testing for Huntington's disease. BMJ 1989;298:892.","journal-title":"BMJ"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ajmg.1320390408","article-title":"Understanding the decision to take the predictive test for Huntington disease","volume":"39","author":"Meissen, G.J.; Mastromauro, C.A.; Kiely, D.K.; McNamara, D.S.; Myers, R.H.","year":"1991","unstructured":"Meissen GJ, Mastromauro CA, Kiely DK, McNamara DS, Myers RH. Understanding the decision to take the predictive test for Huntington disease. Aml. Med Genet 1991;39: 404-10.","journal-title":"Aml. Med Genet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1399-0004.1992.tb03407.x","article-title":"One hundred requests for predictive testing for Huntington's disease","volume":"41","author":"Simpson, S.A.; Besson, J.; Alexander, D.; Allan, K.; Johnston, A.W.","year":"1992","unstructured":"Simpson SA, Besson J, Alexander D, Allan K, Johnston AW. One hundred requests for predictive testing for Huntington's disease. Clin Genet 1992;41:326-30.","journal-title":"Clin Genet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jmg.34.1.63","article-title":"Preparing for presymptomatic DNA testing for early onset Alzheimer's disease\/cerebral haemorrhage and hereditary Pick disease","volume":"34","author":"Tibben, A.; Stevens, M.; van der Wert, G.M.W.R.; Niermeijer, M.F.; van Duijn, C.M.; van Swieten, J.C.","year":"1997","unstructured":"Tibben A, Stevens M, van der Wert GMWR, Niermeijer MF, van Duijn CM, van Swieten JC. Preparing for presymptomatic DNA testing for early onset Alzheimer's disease\/cerebral haemorrhage and hereditary Pick disease. JMed Genet 1997;34:63-72.","journal-title":"JMed Genet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(95)91424-2","article-title":"Genetic testing in breast\/ovarian cancer (BRCA1) families","volume":"346","author":"Watson, M.; Murday, V.; Lloyd, S.; Ponder, B.; Averill, D.; Eeles, R.","year":"1995","unstructured":"Watson M, Murday V, Lloyd S, Ponder B, Averill D, Eeles R. Genetic testing in breast\/ovarian cancer (BRCA1) families. Lancet 1995;346:583.","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ajmg.1320420417","article-title":"Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk","volume":"42","author":"Huggins, M.; Bloch, M.; Wiggins, S.","year":"1992","unstructured":"Huggins M, Bloch M, Wiggins S, et al. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am JMed Genet 1992;42:508-15.","journal-title":"Am JMed Genet"},{"key":"ref_29","article-title":"The troubled helix; social and psychological implications of the new human genetics","author":"Marteau, T.M.; Richards, M.P.M.","year":"1996","unstructured":"Marteau TM, Richards MPM. The troubled helix; social and psychological implications of the new human genetics. Cambridge: Cambridge University Press, 1996."},{"key":"ref_30","article-title":"BRCA1 in the family; a case description of the psychological interaction. Am.7 Med Genet","author":"de Wit AC, Dudok; A, Tibben; PG, Frets","unstructured":"Dudok de Wit AC, Tibben A, Frets PG, et al. BRCA1 in the family; a case description of the psychological interaction. Am.7 Med Genet (in press)."},{"key":"ref_31","first-page":"151","article-title":"Partners of Huntington patients: implications of the disease and opinions about predictive testing and prenatal diagnosis","volume":"1","author":"Evers-Kiebooms, G.; Swerts, A.; Van Den Berghe, H.","year":"1990","unstructured":"Evers-Kiebooms G, Swerts A, Van Den Berghe H. Partners of Huntington patients: implications of the disease and opinions about predictive testing and prenatal diagnosis. Genet Couns 1990; 1: 151-9.","journal-title":"Genet Couns"},{"key":"ref_32","first-page":"145","article-title":"Forgotten person in the Huntington disease family","volume":"48","author":"Kessler, S.","year":"1993","unstructured":"Kessler S. Forgotten person in the Huntington disease family. Am_JMed Genet 1993;48:145-50.","journal-title":"Am_JMed Genet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajmg.1320570111","article-title":"Exploration of the effects of predictive testing for Huntington disease on intimate relationships","volume":"57","author":"Quaid, K.A.; Wesson, M.K.","year":"1995","unstructured":"Quaid KA, Wesson MK. Exploration of the effects of predictive testing for Huntington disease on intimate relationships. Am.7 Med Genet 1995;57:46-5 1.","journal-title":"Am.7 Med Genet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajmg.1320480209","article-title":"On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program","volume":"48","author":"Tibben, A.; Frets, P.G.; van de Kamp, J.J.P.","year":"1993","unstructured":"Tibben A, Frets PG, van de Kamp JJP, et al. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am JMed Genet 1993;48:103-1 1.","journal-title":"Am JMed Genet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1037\/0278-6133.16.1.20","article-title":"3-year follow-up after presymptomatic testing for Huntington disease in tested individuals and partners","volume":"16","author":"Tibben, A.; Timman, R.; Bannink, E.C.; Duivenvoorden, H.J.","year":"1997","unstructured":"Tibben A, Timman R, Bannink EC, Duivenvoorden HJ. 3-year follow-up after presymptomatic testing for Huntington disease in tested individuals and partners. Health Psychol 1997;16:20-35.","journal-title":"Health Psychol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archpsyc.1975.01760290125015","article-title":"Intrusive and repetitive thoughts after experimental stress","volume":"32","author":"Horowitz, M.J.","year":"1975","unstructured":"Horowitz MJ. Intrusive and repetitive thoughts after experimental stress. Arch Gen Psychiatry 1975;32:1457-63.","journal-title":"Arch Gen Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1980.01780140087010","article-title":"Signs and symptoms of posttraumatic stress disorder","volume":"37","author":"Horowitz, M.J.; Wilner, N.; Kaltreider, N.; Alvarez, W.","year":"1980","unstructured":"Horowitz MJ, Wilner N, Kaltreider N, Alvarez W Signs and symptoms of posttraumatic stress disorder. Arch Gen Psychiatry 1980;37:85-92.","journal-title":"Arch Gen Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","article-title":"Impact of Event Scale: a measure of subjective stress","volume":"41","author":"Horowitz, M.J.; Wilner, N.; Alvarez, W.","year":"1979","unstructured":"Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-18.","journal-title":"Psychosom Med"},{"key":"ref_39","article-title":"Personality; dynamzics, development and assessment","author":"Janis, I.L.; Mahl, G.F.; Kagan, J.; Holt, R.R.","year":"1969","unstructured":"Janis IL, Mahl GF, Kagan J, Holt RR. Personality; dynamzics, development and assessment. New York: Harcourt, Brace & World, 1969."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jmg.30.12.996","article-title":"Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range","volume":"30","author":"KE, De Rooij; PA, De Koning Gans; MI, Skraastad","year":"1993","unstructured":"De Rooij KE, De Koning Gans PA, Skraastad MI, et al. Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range. 7 Med Genet 1993;30:996-1002.","journal-title":"7 Med Genet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0140-6736(93)92974-X","article-title":"Borderline repeat expansion in Huntington's disease","volume":"342","author":"KE, De Rooij; de Koning Gans PA; M, Losekoot","year":"1993","unstructured":"De Rooij KE, de Koning Gans PA, Losekoot M, et al. Borderline repeat expansion in Huntington's disease. Lancet 1993;342: 1491-2.","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0888-7543(92)90032-N","article-title":"Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis","volume":"13","author":"Fodde, R.; van der Luijt, R.; Wijnen, J.","year":"1992","unstructured":"Fodde R, van der Luijt R, Wijnen J, et al. Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis. Genomics 1992;13: 1162-8.","journal-title":"Genomics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/humu.1380080102","article-title":"Mutations and polymorphisms in the familial early onset breast cancer (BRCAI) gene","volume":"8","author":"Couch, F.J.; Weber, B.L.","year":"1996","unstructured":"Couch FJ, Weber BL. Mutations and polymorphisms in the familial early onset breast cancer (BRCAI) gene. Hum Mutat 1996;8:8-18.","journal-title":"Hum Mutat"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng0695-208","article-title":"Rapid detection of BRCA1 mutations by the protein truncation test","volume":"1","author":"Hogervorst, F.B.; Cornelis, R.S.; Bout, M.","year":"1995","unstructured":"Hogervorst FB, Cornelis RS, Bout M, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 1995;1O:208-12.","journal-title":"Nat Genet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ajmg.1320480105","article-title":"Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program","volume":"48","author":"Tibben, A.; Frets, P.G.; van de Kamp, J.J.P.","year":"1993","unstructured":"Tibben A, Frets PG, van de Kamp JJP, et al. Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Anm 7 Med Genet 1993;48:10-16.","journal-title":"Anm 7 Med Genet"},{"key":"ref_46","first-page":"407","article-title":"Impact of Event Scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. _7 Cons Clin Psychol","volume":"50","author":"Zilberg, N.J.; Weiss, D.S.; Horowitz, M.J.","year":"1982","unstructured":"Zilberg NJ, Weiss DS, Horowitz MJ. Impact of Event Scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. _7 Cons Clin Psychol 1982;50:407-14."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1037\/0022-006X.55.2.251","article-title":"Validation of the impact of event scale for psychological sequelae of combat","volume":"55","author":"Schwarzwald, J.; Solomon, Z.; Weisenberg, M.; Mikulincer, M.","year":"1987","unstructured":"Schwarzwald J, Solomon Z, Weisenberg M, Mikulincer M. Validation of the impact of event scale for psychological sequelae of combat.J Cons Clin Psychol 1987;55:251-6.","journal-title":"J Cons Clin Psychol"},{"key":"ref_48","first-page":"1401","article-title":"The psychological consequences of predictive testing for Huntington's disease. Canadian collaborative study of predictive testing","volume":"327","author":"Wiggins, S.; Whyte, P.; Huggins, M.","year":"1992","unstructured":"Wiggins S, Whyte P, Huggins M, et al. The psychological consequences of predictive testing for Huntington's disease. Canadian collaborative study of predictive testing. NEngl3rMed 1992;327:1401-5."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajmg.1320480305","article-title":"Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention","volume":"48","author":"Tibben, A.; Duivenvoorden, H.J.; Vegter-van der Vlis, M.","year":"1993","unstructured":"Tibben A, Duivenvoorden HJ, Vegter-van der Vlis M, et al. Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention. Anm. Med Genet 1993;48:137-44.","journal-title":"Anm. Med Genet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1037\/0003-066X.48.11.1117","article-title":"The illusion of mental health","volume":"48","author":"Shedler, J.; Mayman, M.; Manis, M.","year":"1993","unstructured":"Shedler J, Mayman M, Manis M. The illusion of mental health. Am Psychol 1993;48: 1117-31.","journal-title":"Am Psychol"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmg.28.8.515","article-title":"Age at onset in Huntington's disease: effect of line of inheritance and patient's sex","volume":"28","author":"Roos, R.A.C.; Vegter-van der Vlis, M.; Hermans, J.","year":"1991","unstructured":"Roos RAC, Vegter-van der Vlis M, Hermans J, et al. Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. 7 Med Genet 1991;28:515-19.","journal-title":"7 Med Genet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0303-8467(89)90003-6","article-title":"Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Research group hereditary cerebral amyloid angiopathy","volume":"91","author":"Haan, J.; Roos, R.A.C.; Briet, P.E.; Herpers, M.J.; Luyendijk, W.; Bots, G.T.","year":"1989","unstructured":"Haan J, Roos RAC, Briet PE, Herpers MJ, Luyendijk W, Bots GT. Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Research group hereditary cerebral amyloid angiopathy. Clin Neurol Neurosuirg 1989;91: 285-90.","journal-title":"Clin Neurol Neurosuirg"},{"key":"ref_53","first-page":"30","article-title":"The expanding spectrum of familial adenomatous polyposis","volume":"1","author":"Jagelman, D.","year":"1988","unstructured":"Jagelman D. The expanding spectrum of familial adenomatous polyposis. Perspect Colon Rectal Surg 1988;1:30-46.","journal-title":"Perspect Colon Rectal Surg"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00223866","article-title":"Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer","volume":"95","author":"Cornelis, R.S.; Vasen, H.F.; Meijers-Heijboer, H.","year":"1995","unstructured":"Cornelis RS, Vasen HF, Meijers-Heijboer H, et al. Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer. Hum Genet 1995;95:539-44.","journal-title":"Hum Genet"},{"key":"ref_55","first-page":"75","article-title":"Breast cancer: demands of the illness on the patient's partner","volume":"9","author":"Zahlis, E.H.; Shands, M.E.","year":"1991","unstructured":"Zahlis EH, Shands ME. Breast cancer: demands of the illness on the patient's partner. _7 Psychosoc Oncol 1991;9: 75-93."},{"key":"ref_56","article-title":"Huntingtonz's disease","author":"Harper, P.S.","year":"1991","unstructured":"Harper PS. Huntingtonz's disease. London: Saunders, 1991."},{"key":"ref_57","first-page":"678","article-title":"Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families","volume":"52","author":"Easton, D.F.; Bishop, D.T.; Ford, D.; Crockford, G.P.","year":"1993","unstructured":"Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am I Hum Genet 1993;52:678-70 1.","journal-title":"The Breast Cancer Linkage Consortium. Am I Hum Genet"},{"key":"ref_58","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCAl-mutation carriers. Breast Cancer Linkage Consortium. An.7 Hunm","volume":"56","author":"Easton, D.F.; Ford, D.; Bishop, D.T.","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCAl-mutation carriers. Breast Cancer Linkage Consortium. An.7 Hunm Genet 1995;56:265-7 1.","journal-title":"Genet"},{"key":"ref_59","first-page":"692","article-title":"Risks of cancer in BRCA1-mutation carriers","volume":"343","author":"Ford, D.; Easton, D.F.; Bishop, D.T.; Narod, S.A.; Goldgar, D.E.","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-5.","journal-title":"Breast Cancer Linkage Consortium. Lancet"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.34.5.382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:54:39Z","timestamp":1760774079000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.34.5.382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1997,5,1]]},"published-print":{"date-parts":[[1997,5]]}},"alternative-id":["10.1136\/jmg.34.5.382"],"URL":"https:\/\/doi.org\/10.1136\/jmg.34.5.382","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}